Filings For: 20/20 Biolabs, Inc.
WHO USES CALCBENCH?    Equity Analysts    Corparate Finance & Reporting    Auditors    Academics

GO TO: Recent Comment Letters


Today


ALL   |    All 10-K/Qs   Large   Mid    Small    Micro    |     Earnings Release    Proxy    |   SORT BY :   Most Recent    Company Name 
CompanyTimeSizeViewFinancialsDocumentSECPeriodRevenue MRQAssetsEPS Diluted
20/20 Biolabs, Inc. (AIDX) 8/17/2026 4:07:54 PM   View Financials Earnings SEC 2Q 2026 Rev $730,571 Assets $6,123,185 EPS -$0.26 Export Earnings Model
20/20 Biolabs, Inc. (AIDX) 8/15/2026 4:04:04 AM Micro View Financials 10-Q SEC 2Q 2026 ending: 6/30/2026
20/20 Biolabs, Inc. (AIDX) 6/23/2026 5:03:28 PM   View Proxy SEC Y 2025
20/20 Biolabs, Inc. (AIDX) 5/20/2026 4:20:12 PM Micro View Financials 10-Q SEC 1Q 2026 ending: 3/31/2026
20/20 Biolabs, Inc. (AIDX) 5/20/2026 4:11:54 PM   View Financials Earnings SEC 1Q 2026 Rev $353,375 Assets $5,803,347 EPS -$0.28 Export Earnings Model
20/20 Biolabs, Inc. (AIDX) 4/1/2026 6:03:12 AM   View Financials Earnings SEC 1Q 2026 Rev $353,375 Assets $5,803,347 EPS -$0.28 Export Earnings Model
20/20 Biolabs, Inc. (AIDX) 3/31/2026 5:35:12 PM Micro View Financials 10-K SEC Y 2025 ending: 12/31/2025